FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
1-Year Return
33.17%
This Quarter Return
+18.27%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.08B
AUM Growth
+$89.3M
(+9%)
Cap. Flow
+$17.6M
Cap. Flow
% of AUM
1.63%
Top 10 Holdings %
Top 10 Hldgs %
53.14%
Holding
94
New
23
Increased
12
Reduced
34
Closed
20
Top Buys
Top Sells
| 1 |
MODN
MODEL N, INC.
MODN
|
$13.2M |
| 2 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
$12.5M |
| 3 |
Mirum Pharmaceuticals
MIRM
|
$11M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$10.2M |
| 5 |
CareDx
CDNA
|
$9.36M |
Sector Composition
| 1 | Healthcare | 86.01% |
| 2 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Takeda Pharmaceutical
TAK
$48.1B
| $400K | 0.04% |
25,630
| – | – |
|
52
Gilead Sciences
GILD
$140B
| $389K | 0.04% |
4,526
-2,179
| -32% | -$187K |
|
53
Enovis
ENOV
$1.8B
| $386K | 0.04% |
+7,203
| New | +$386K |
|
54
Johnson & Johnson
JNJ
$429B
| $382K | 0.04% |
2,161
| – | – |
|
55
Novartis
NVS
$249B
| $374K | 0.03% |
+4,123
| New | +$374K |
|
56
United Therapeutics
UTHR
$17.3B
| $374K | 0.03% |
1,345
-1,121
| -45% | -$312K |
|
57
Sanofi
SNY
$112B
| $373K | 0.03% |
7,711
+1,061
| +16% | +$51.4K |
|
58
Viatris
VTRS
$12.1B
| $367K | 0.03% |
+33,010
| New | +$367K |
|
59
QuidelOrtho
QDEL
$1.87B
| $365K | 0.03% |
+4,257
| New | +$365K |
|
60
Organon & Co
OGN
$2.52B
| $355K | 0.03% |
+12,716
| New | +$355K |
|
61
GSK
GSK
$79.6B
| $353K | 0.03% |
10,058
| – | – |
|
62
Qiagen
QGEN
$10.1B
| $345K | 0.03% |
+6,518
| New | +$345K |
|
|
BAY
63
DELISTED
BAYER AG SPONS ADR
BAY
| $328K | 0.03% |
+25,475
| New | +$328K |
|
64
Medtronic
MDT
$120B
| $325K | 0.03% |
+4,188
| New | +$325K |
|
65
Fresenius Medical Care
FMS
$14.2B
| $318K | 0.03% |
+19,490
| New | +$318K |
|
66
Revvity
RVTY
$9.79B
| $312K | 0.03% |
+2,223
| New | +$312K |
|
67
Avantor
AVTR
$8.84B
| $308K | 0.03% |
14,596
| – | – |
|
68
Biogen
BIIB
$20.3B
| $304K | 0.03% |
+1,096
| New | +$304K |
|
69
Exelixis
EXEL
$10B
| $296K | 0.03% |
+18,445
| New | +$296K |
|
70
Labcorp
LH
$22.8B
| $287K | 0.03% |
+1,418
| New | +$287K |
|
71
HCA Healthcare
HCA
$97B
| $278K | 0.03% |
+1,160
| New | +$278K |
|
72
Dentsply Sirona
XRAY
$2.83B
| $262K | 0.02% |
+8,228
| New | +$262K |
|
|
PDCO
73
DELISTED
Patterson Companies, Inc.
PDCO
| $260K | 0.02% |
+9,264
| New | +$260K |
|
|
SYNH
74
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $210K | 0.02% |
5,736
| – | – |
|
75
AbbVie
ABBV
$376B
| – | – |
-3,740
| Closed | -$502K |
|